Solventum rises after lifting annual profit forecast

** Shares of medical device maker Solventum SOLV.N rise 1.8% to $73.24 premarket

** Co late on Thursday raised its full-year adjusted profit forecast, driven by strong sales of its wound care and surgical sterilization products and lower expenses

** Co now expects its 2025 adjusted profit per share to be in the range of $5.80 to $5.95, vs its previous estimate of $5.45 to $5.65 per share

** Co reported Q2 adj.profit of $1.69 per share, higher than analysts' estimates of $1.44 per share, according to data compiled by LSEG

** Sales in its MedSurg business, which provides wound dressings and surgical equipment, rose 4.8% to $1.22 billion in Q2

** Up to last close, stock up 8.9% YTD